Synaptic proteins in Alzheimer’s disease

被引:0
|
作者
Josef Marksteiner
Walter A. Kaufmann
Peter Gurka
Christian Humpel
机构
[1] University Innsbruck,Institute for Biochemical Pharmacology, Department of Psychiatry
来源
关键词
Chromogranin A; Chromogranin B; Secretogranin II; Immunocytochemistry; Large dense core vesicles;
D O I
暂无
中图分类号
学科分类号
摘要
Chromogranin A, chromogranin B, and secretogranin II are acidic proteins which are stored in large dense core vesicles of neurons. An antiserum, raised against a synthetic peptide (PE-11), present in the chromogranin B molecule, and an antiserum raised against secretoneurin contained in the secretogranin II sequence, was used to localize these peptides together with chromogranin A in the human hippocampal formation. The distribution of these peptides was investigated in Alzheimer’s disease and compared to control subjects.
引用
收藏
页码:53 / 63
页数:10
相关论文
共 50 条
  • [21] Synaptic slaughter in Alzheimer's disease
    Coleman, PD
    Yao, PJ
    [J]. NEUROBIOLOGY OF AGING, 2003, 24 (08) : 1023 - 1027
  • [22] Synaptic pathology in Alzheimer's disease
    Marie, H.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2017, 142 : 35 - 35
  • [23] Cerebrospinal Fluid Panel of Synaptic Proteins in Cerebral Amyloid Angiopathy and Alzheimer's Disease
    van den Berg, Emma
    Nilsson, Johanna
    Kersten, Iris
    Brinkmalm, Gunnar
    de Kort, Anna M.
    Klijn, Catharina J. M.
    Schreuder, Floris H. B. M.
    Jakel, Lieke
    Gobom, Johan
    Portelius, Erik
    Zetterberg, Henrik
    Brinkmalm, Ann
    Blennow, Kaj
    Kuiperij, H. Bea
    Verbeek, Marcel M.
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2023, 92 (02) : 467 - 475
  • [24] Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer's disease
    Duits, Flora H.
    Brinkmalm, Gunnar
    Teunissen, Charlotte E.
    Brinkmalm, Ann
    Scheltens, Philip
    Van der Flier, Wiesje M.
    Zetterberg, Henrik
    Blennow, Kaj
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2018, 10
  • [25] Differential involvement of synaptic vesicle and presynaptic plasma membrane proteins in Alzheimer's disease
    Shimohama, S
    Kamiya, S
    Taniguchi, T
    Akagawa, K
    Kimura, J
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 236 (02) : 239 - 242
  • [26] Genetic Variants of Synaptic Vesicle and Presynaptic Plasma Membrane Proteins In Alzheimer's Disease
    Edgunlu, Tuba Gokdogan
    Ozge, Aynur
    Yalin, Osman Ozgur
    Kul, Seval
    Erdal, Mehmet Emin
    [J]. NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2012, 49 (04): : 294 - 299
  • [27] Transient upregulation of synaptic vesicle proteins in neocortex at early stages of Alzheimer's disease
    Mukaetova-Ladinska, EB
    Garcia-Siera, F
    Gertz, HJ
    Hurt, J
    Xuereb, JH
    Wischik, CM
    [J]. ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 1999, 32 (02): : 96 - 96
  • [28] Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia
    Bereczki, Erika
    Francis, Paul T.
    Howlett, David
    Pereira, Joana B.
    Hoglund, Kina
    Bogstedt, Anna
    Cedazo-Minguez, Angel
    Baek, Jean-Ha
    Hortobagyi, Tibor
    Attems, Johannes
    Ballard, Clive
    Aarsland, Dag
    [J]. ALZHEIMERS & DEMENTIA, 2016, 12 (11) : 1149 - 1158
  • [29] Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
    Flora H. Duits
    Gunnar Brinkmalm
    Charlotte E. Teunissen
    Ann Brinkmalm
    Philip Scheltens
    Wiesje M. Van der Flier
    Henrik Zetterberg
    Kaj Blennow
    [J]. Alzheimer's Research & Therapy, 10
  • [30] Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease
    Masliah, E
    Mallory, M
    Alford, M
    DeTeresa, R
    Hansen, LA
    McKeel, DW
    Morris, JC
    [J]. NEUROLOGY, 2001, 56 (01) : 127 - 129